XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 395,776 $ 459,453
Accounts receivable, net 1,095,808 938,743
Inventories 831,700 801,100
Prepaid expenses and other current assets 45,744 48,493
Restricted cash 8,607 160,527
Total current assets 2,377,635 2,408,316
Property, plant and equipment, net 6,316,731 6,420,062
Other assets, net    
Goodwill 999,614 946,553
Customer relationships, net 654,092 611,615
Other intangible assets, net 169,991 175,839
Deferred charges and other assets, net 367,644 327,868
Total other assets, net 2,191,341 2,061,875
Total assets 10,885,707 10,890,253
Current liabilities    
Accounts payable 583,509 496,259
Accrued liabilities 447,412 537,483
Term loan 0 149,341
Total current liabilities 1,030,921 1,183,083
Long-term debt, net 3,489,900 3,678,654
Deferred income taxes 1,648,529 1,650,575
Pension and other post-retirement benefits 366,916 364,819
Other liabilities 140,398 121,077
Total liabilities 6,676,664 6,998,208
Stockholders' equity    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and 134,651,380 shares issued at June 30, 2017 and December 31, 2016, respectively 1,347 1,347
Common stock, held in treasury, at cost; 5,598,476 and 5,726,377 shares at June 30, 2017 and December 31, 2016, respectively (316,152) (319,339)
Additional paid-in capital 555,478 550,641
Retained earnings 3,653,988 3,412,286
Accumulated other comprehensive loss (53,824) (121,306)
Total Westlake Chemical Corporation stockholders' equity 3,840,837 3,523,629
Noncontrolling interests 368,206 368,416
Total equity 4,209,043 3,892,045
Total liabilities and equity $ 10,885,707 $ 10,890,253